C Jasmin

8.6k total citations · 1 hit paper
242 papers, 6.7k citations indexed

About

C Jasmin is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, C Jasmin has authored 242 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Immunology, 62 papers in Oncology and 42 papers in Molecular Biology. Recurrent topics in C Jasmin's work include Immune Cell Function and Interaction (38 papers), Immunotherapy and Immune Responses (22 papers) and Virus-based gene therapy research (19 papers). C Jasmin is often cited by papers focused on Immune Cell Function and Interaction (38 papers), Immunotherapy and Immune Responses (22 papers) and Virus-based gene therapy research (19 papers). C Jasmin collaborates with scholars based in France, Italy and United States. C Jasmin's co-authors include Marie‐Caroline Le Bousse‐Kerdilès, Eric Rubinstein, Claude Boucheix, Bruno Azzarone, Denis Clay, Florence Smadja‐Joffe, M Prenant, Françis Lévi, François Le Naour and Danièle Brouty‐Boyé and has published in prestigious journals such as Nature, Science and Journal of Clinical Investigation.

In The Last Decade

C Jasmin

231 papers receiving 6.4k citations

Hit Papers

Severely Reduced Female Fertility in CD9-Deficient Mice 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Jasmin France 37 2.3k 1.7k 1.6k 1.3k 673 242 6.7k
Robert I. Fox United States 48 1.5k 0.7× 1.7k 1.0× 3.1k 1.9× 1.1k 0.8× 335 0.5× 137 12.6k
Daniel E. Gómez Argentina 37 1.4k 0.6× 2.6k 1.6× 631 0.4× 883 0.7× 510 0.8× 130 5.9k
David H. Lovett United States 50 995 0.4× 2.5k 1.5× 1.0k 0.6× 693 0.5× 563 0.8× 126 6.6k
Toshihiko Terao Japan 43 683 0.3× 1.6k 1.0× 940 0.6× 876 0.7× 613 0.9× 220 5.8k
Stanley Zucker United States 55 4.2k 1.9× 4.2k 2.5× 1.2k 0.8× 1.6k 1.3× 838 1.2× 161 9.6k
Reuven Reich Israel 59 3.0k 1.3× 5.4k 3.3× 1.8k 1.1× 993 0.8× 863 1.3× 202 11.2k
Robert Auerbach United States 41 842 0.4× 3.4k 2.1× 1.2k 0.8× 521 0.4× 448 0.7× 124 6.8k
Toni Antalis United States 40 846 0.4× 2.5k 1.5× 838 0.5× 876 0.7× 341 0.5× 91 5.7k
A. J. H. Gearing United Kingdom 48 2.0k 0.9× 2.9k 1.8× 2.9k 1.8× 1.1k 0.9× 557 0.8× 90 10.0k
Fabien Calvo France 45 2.3k 1.0× 3.3k 2.0× 842 0.5× 601 0.5× 606 0.9× 160 6.7k

Countries citing papers authored by C Jasmin

Since Specialization
Citations

This map shows the geographic impact of C Jasmin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Jasmin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Jasmin more than expected).

Fields of papers citing papers by C Jasmin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Jasmin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Jasmin. The network helps show where C Jasmin may publish in the future.

Co-authorship network of co-authors of C Jasmin

This figure shows the co-authorship network connecting the top 25 collaborators of C Jasmin. A scholar is included among the top collaborators of C Jasmin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Jasmin. C Jasmin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jasmin, C. (2005). Textbook of bone metastases. CINECA IRIS Institutial research information system (University of Pisa). 18 indexed citations
3.
Brouty‐Boyé, Danièle, et al.. (2002). Fibroblasts from Human Spleen Regulate NK Cell Differentiation from Blood CD34+ Progenitors Via Cell Surface IL-15. The Journal of Immunology. 168(9). 4326–4332. 63 indexed citations
4.
Butler, Robert N. & C Jasmin. (2000). Longevity and quality of life : opportunities and challenges. 12 indexed citations
5.
Giron‐Michel, Julien, Alessia Gaggero, Raffaella Meazza, et al.. (2000). IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα. Oncogene. 19(45). 5153–5162. 58 indexed citations
7.
Doucet, Christelle, Raffaella Meazza, M. Scudeletti, et al.. (1997). Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient. Melanoma Research. 7(SUPPLEMENT 2). S19–S19. 9 indexed citations
8.
Jasmin, C, et al.. (1995). Chimiothérapie des sarcomes ostéogéniques.. Chirurgie. 120(13).
9.
Jasmin, C, et al.. (1993). Cancer, sida et société : pour une approche globale de la santé. Medical Entomology and Zoology. 1 indexed citations
11.
Uriel, José, Yanto Lunardi-Iskandar, Jorge Laborda, et al.. (1990). Defective Uptake of Alpha-Fetoprotein (AFP) and Transferrin (Tf) by PHA-Activated Peripheral Blood Lymphocytes from Patients with AIDS and Related Syndromes. AIDS Research and Human Retroviruses. 6(3). 401–410. 5 indexed citations
12.
Fredj, G, et al.. (1989). Tetrahydroaminoacridine in HIV infections. The THA Study Group.. PubMed. 27(8). 408–10. 1 indexed citations
13.
Jasmin, C. (1982). La petite patrie. 2 indexed citations
14.
Mathé, G, J. L. Misset, F. de Vassal, et al.. (1978). Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.. PubMed. 62(5). 805–9. 47 indexed citations
15.
Larnicol, Nicole, et al.. (1977). Effect of the nitrosourea derivative rpcnu (ICIG 1163) on the development of Friend leukemia in mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(3). 176–81. 3 indexed citations
16.
Amiel, Jeanne, L Schwarzenberg, P Pouillart, et al.. (1975). Immunothérapie active des leucémies aiguës et des lymphosarcomes leucémiques. Bilar de 10 ans-Etude de 200 cas. ˜La œNouvelle presse médicale. 4(18). 3 indexed citations
17.
Jl, Misset, P Pouillart, Amiel Jl, et al.. (1975). [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].. PubMed. 4(44). 3117–20. 1 indexed citations
18.
Schwarzenberg, L, et al.. (1968). Haute fréquence et qualité des rémissions de la leucémie aiguü lymphoblastique chez l'enfant. Induites par l'association de data-1-cortisone, leurocristine et rubidomycine. Intérêt des chambres exemptes de germes pathogènes.. 25(2). 2 indexed citations
19.
Jasmin, C, et al.. (1968). Action de l'actinomycine D sur la maladie de Friend.. 13(3). 1 indexed citations
20.
Mathé, G, Jeanne Amiel, L Schwarzenberg, et al.. (1968). Greffe de moelle osseuse allogénique chez l'hormme provée par six marqueurs antigéniques après conditionnnement du receveur et du donneur par le sérum antilymphocytaire.. 13(10). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026